{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T23:07:12Z","timestamp":1789168032066,"version":"build-2803163510"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.carrev.2014.02.005","type":"journal-article","created":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T23:16:15Z","timestamp":1393715775000},"page":"141-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Type 2 diabetes impairs venous, but not arterial smooth muscle cell function: Possible role of differential RhoA activity"],"prefix":"10.1016","volume":"15","author":[{"given":"Kirsten","family":"Riches","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Warburton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"O\u2019Regan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil A.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen E.","family":"Porter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 2","key":"10.1016\/j.carrev.2014.02.005_bb0005","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1007\/PL00002934","article-title":"Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes","volume":"44","author":"Morrish","year":"2001","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.carrev.2014.02.005_bb0010","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2337\/diacare.25.7.1129","article-title":"Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes","volume":"25","author":"Hu","year":"2002","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.carrev.2014.02.005_bb0015","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/01.CIR.97.9.916","article-title":"Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention","volume":"97","author":"Motwani","year":"1998","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.carrev.2014.02.005_bb0020","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.athoracsur.2004.10.035","article-title":"Effect of risk-adjusted diabetes on mortality and morbidity after coronary artery bypass surgery","volume":"79","author":"Kubal","year":"2005","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.carrev.2014.02.005_bb0025","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.jtcvs.2012.04.024","article-title":"Long-term outcomes of patients with diabetes receiving bilateral internal thoracic artery grafts","volume":"146","author":"Hemo","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.carrev.2014.02.005_bb0030","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0008-6363(97)00056-4","article-title":"Contrasting structure of the saphenous vein and internal mammary artery used as coronary bypass vessels","volume":"34","author":"Canham","year":"1997","journal-title":"Cardiovasc Res"},{"issue":"11","key":"10.1016\/j.carrev.2014.02.005_bb0035","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.2337\/diabetes.52.11.2814","article-title":"Influence of type 2 diabetes on functional and structural properties of coronary artery bypass conduits","volume":"52","author":"Lorusso","year":"2003","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.carrev.2014.02.005_bb0040","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jvs.2009.07.102","article-title":"Adaptive changes in autogenous vein grafts for arterial reconstruction: clinical implications","volume":"51","author":"Owens","year":"2010","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1016\/j.carrev.2014.02.005_bb0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/jcb.10497","article-title":"ERK, JNK, and p38 MAP kinases differentially regulate proliferation and migration of phenotypically distinct smooth muscle cell subtypes","volume":"89","author":"Kavurma","year":"2003","journal-title":"J Cell Biochem"},{"issue":"3","key":"10.1016\/j.carrev.2014.02.005_bb0050","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1161\/01.ATV.21.3.300","article-title":"Cytoskeletal effects of rho-like small guanine nucleotide-binding proteins in the vascular system","volume":"21","author":"van Nieuw Amerongen","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.carrev.2014.02.005_bb0055","doi-asserted-by":"crossref","first-page":"H1051","DOI":"10.1152\/ajpheart.00710.2004","article-title":"RhoA and resistance artery remodeling","volume":"288","author":"Loirand","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"6","key":"10.1016\/j.carrev.2014.02.005_bb0060","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2337\/db07-1149","article-title":"RhoA\/Rho-kinase contribute to the pathogenesis of diabetic renal disease","volume":"57","author":"Peng","year":"2008","journal-title":"Diabetes"},{"issue":"8","key":"10.1016\/j.carrev.2014.02.005_bb0065","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/aps.2011.54","article-title":"Involvement of RhoA\/ROCK in myocardial fibrosis in a rat model of type 2 diabetes","volume":"32","author":"Zhou","year":"2011","journal-title":"Acta Pharmacol Sin"},{"issue":"5","key":"10.1016\/j.carrev.2014.02.005_bb0070","doi-asserted-by":"crossref","first-page":"C1307","DOI":"10.1152\/ajpcell.00608.2008","article-title":"Inherent differences in morphology, proliferation, and migration in saphenous vein smooth muscle cells cultured from nondiabetic and Type 2 diabetic patients","volume":"297","author":"Madi","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10.1016\/j.carrev.2014.02.005_bb0075","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1067\/mva.2002.122029","article-title":"Simvastatin inhibits human saphenous vein neointima formation via inhibition of smooth muscle cell proliferation and migration","volume":"36","author":"Porter","year":"2002","journal-title":"J Vasc Surg"},{"issue":"1","key":"10.1016\/j.carrev.2014.02.005_bb0080","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cardiores.2007.06.003","article-title":"Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: effects of statins and thiazolidinediones","volume":"76","author":"Turner","year":"2007","journal-title":"Cardiovasc Res"},{"issue":"4","key":"10.1016\/j.carrev.2014.02.005_bb0085","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0898-6568(01)00135-8","article-title":"The mechanism of angiotensin II-induced extracellular signal-regulated kinase-1\/2 activation is independent of angiotensin AT(1A) receptor internalisation","volume":"13","author":"Turner","year":"2001","journal-title":"Cell Signal"},{"issue":"5","key":"10.1016\/j.carrev.2014.02.005_bb0090","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.jvs.2007.01.061","article-title":"Smooth muscle cells cultured from human saphenous vein exhibit increased proliferation, invasion, and mitogen-activated protein kinase activation in vitro compared with paired internal mammary artery cells","volume":"45","author":"Turner","year":"2007","journal-title":"J Vasc Surg"},{"issue":"2","key":"10.1016\/j.carrev.2014.02.005_bb0095","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.atherosclerosis.2007.06.029","article-title":"Expansive remodeling in venous bypass grafts: novel implications for vein graft disease","volume":"196","author":"Wong","year":"2008","journal-title":"Atherosclerosis"},{"issue":"3","key":"10.1016\/j.carrev.2014.02.005_bb0100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/cm.1027","article-title":"Vascular smooth muscle cell phenotypic modulation in culture is associated with reorganisation of contractile and cytoskeletal proteins","volume":"49","author":"Worth","year":"2001","journal-title":"Cell Motil Cytoskeleton"},{"issue":"2","key":"10.1016\/j.carrev.2014.02.005_bb0105","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000099141","article-title":"Different Migration Of Vascular Smooth Muscle Cells From Human Coronary Artery Bypass Vessels. Role Of Rho\/ROCK Pathway","volume":"44","author":"Weiss","year":"2007","journal-title":"J Vasc Res"},{"issue":"6","key":"10.1016\/j.carrev.2014.02.005_bb0110","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1165\/rcmb.2006-0034OC","article-title":"Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin","volume":"35","author":"Takeda","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"10.1016\/j.carrev.2014.02.005_bb0115","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1055\/s-0029-1186267","article-title":"Increased RhoA\/ROK mRNA expression and function in diabetic vein grafts compared with nondiabetic vein grafts and diabetic arterial grafts","volume":"58","author":"Ding","year":"2010","journal-title":"Thorac Cardiovasc Surg"},{"issue":"6","key":"10.1016\/j.carrev.2014.02.005_bb0120","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1540-8191.2009.00888.x","article-title":"RhoA\/ROK pathway related to the mechanism of higher susceptibility to spasm in RA than in IMA","volume":"24","author":"Kun","year":"2009","journal-title":"J Card Surg"},{"issue":"2","key":"10.1016\/j.carrev.2014.02.005_bb0125","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.bbrc.2011.07.097","article-title":"The defective protein level of myosin light chain phosphatase (MLCP) in the isolated saphenous vein, as a vascular conduit in coronary artery bypass grafting (CABG), harvested from patients with diabetes mellitus (DM)","volume":"412","author":"Matsuo","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"issue":"8\u20139","key":"10.1016\/j.carrev.2014.02.005_bb0130","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1139\/y05-077","article-title":"Decreased RhoA expression in myocardium of diabetic rats","volume":"83","author":"Tang","year":"2005","journal-title":"Can J Physiol Pharmacol"},{"issue":"2","key":"10.1016\/j.carrev.2014.02.005_bb0135","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","article-title":"MicroRNAs: target recognition and regulatory functions","volume":"136","author":"Bartel","year":"2009","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.carrev.2014.02.005_bb0140","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1164\/rccm.200903-0325OC","article-title":"Down-regulation of miR-133a contributes to up-regulation of Rhoa in bronchial smooth muscle cells","volume":"180","author":"Chiba","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1016\/j.carrev.2014.02.005_bb0145","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.2337\/db09-0165","article-title":"The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c\/myocyte enhancer factor 2C pathway","volume":"58","author":"Granjon","year":"2009","journal-title":"Diabetes"},{"issue":"3","key":"10.1016\/j.carrev.2014.02.005_bb0150","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1152\/physrev.00041.2003","article-title":"Molecular regulation of vascular smooth muscle cell differentiation in development and disease","volume":"84","author":"Owens","year":"2004","journal-title":"Physiol Rev"},{"issue":"4","key":"10.1016\/j.carrev.2014.02.005_bb0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1042\/CS20120413","article-title":"The vascular smooth muscle cell: a therapeutic target in Type 2 diabetes?","volume":"125","author":"Porter","year":"2013","journal-title":"Clin Sci (Lond)"},{"issue":"15","key":"10.1016\/j.carrev.2014.02.005_bb0160","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.carrev.2014.02.005_bb0165","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/nrcardio.2010.35","article-title":"Intensive glycemic control and cardiovascular disease: an update","volume":"7","author":"Brown","year":"2010","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.carrev.2014.02.005_bb0170","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1161\/CIRCULATIONAHA.108.191305","volume":"119","author":"Skyler","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.carrev.2014.02.005_bb0175","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1399-5448.2008.00491.x","article-title":"Metabolic memory: implications for diabetic vascular complications","volume":"10","author":"Cooper","year":"2009","journal-title":"Pediatr Diabetes"},{"issue":"7","key":"10.1016\/j.carrev.2014.02.005_bb0180","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1440-1681.2011.05497.x","article-title":"Epigenetics: deciphering its role in diabetes and its chronic complications","volume":"38","author":"Villeneuve","year":"2011","journal-title":"Clin Exp Pharmacol Physiol"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838914000517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838914000517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:09:29Z","timestamp":1761559769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838914000517"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S1553838914000517"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2014.02.005","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2 diabetes impairs venous, but not arterial smooth muscle cell function: Possible role of differential RhoA activity","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2014.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}